Functionally, knockdown of PFKFB3 results in a reduced migration rate of gastric cancer cells (24), a result consistent with our finding that manipulation of PFKFB3 in CSC-enriched/differentiated subsets affected the migration/invasion capacity of ovarian cancer in vitro. The gene discussed is PFKFB3; the disease is ovarian cancer.